Drug discovery outsourcing – your guide to the commercial potential of services and companies in this market
Where is the drug discovery outsourcing market heading? Visiongain’s new report gives you revenue predictions for the drug discovery outsourcing market and its submarkets from 2015 to 2025, helping you stay ahead.
Our new 223-page report provides 149 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, drivers and restraints, and revenue predictions.
Besides revenue forecast to 2025, this report provides you with market shares, business outlooks, qualitative analyses (including SWOT and Porter’s Five Forces Analysis), company profiles and commercial partnerships. Also, read the full transcript of three exclusive expert opinion interviews to inform you about prospects for investments and sales:
– Dr. Mario Polywka, Chief Operating Officer, Evotec
– Dr. John Davis, Director of Discovery & Dave Roberts, Business Development Director, Radiochemistry, Selcia
– Dr. Paul Overton, Executive VP, Business Development & Marketing, Apuit
See revenue forecasts for leading drug discovery outsourcing sectors
Along with prediction of overall world market value to 2025, our report shows you revenue forecasting for the four services sectors at world level:
• Chemistry services market forecast 2015-2025
• Biology services market forecast 2015-2025
• Lead optimisation market forecast 2015-2025
• Lead identification and screening market forecast 2015-2025
The analysis helps you identify market potential with individual revenue forecasts, annual growth rates and CAGRs and market shares.
Discover prospects of the leading national markets for the drug discovery outsourcing
The drug discovery outsourcing market is becoming increasingly global as companies look to lower costs by off-shoring their work to CROs based in emerging economies.
You will discover individual revenue forecasts, annual growth rates, CAGRs, and market shares to 2025, as well as written supporting analyses for each of the 13 leading national markets and the rest of the world (RoW):
• US
• Japan
• Germany
• France
• UK
• Italy
• Spain
• China
• Brazil
• Russia
• India
• South Korea
• Mexico
• Rest of the World
Demand for CROs based in emerging markets will be a major driver of growth in this market.
Leading companies and potential for market growth
Our new study predicts the world market for drug discovery outsourcing will reach $16.6bn in 2015. There is the increasing trend for pharmaceutical and biotech companies to form partnerships and alliances with CROs during the early drug discovery phase.
Our research profiles leading companies, assessing their financial performance and products. You will see which organisations hold the greatest potential and what services each offer. See the profiles of 14 leading companies:
• Albany Molecular Research (AMRI)
• Aptuit
• Charles River Laboratories (Acquired Galapagos CRO in 2014)
• Covance (Acquired by LabCorp in 2015)
• Cyprotex
• Domainex
• Evotec
• GenScript
• Pharmaceutical Product Development (PPD)
• Quintiles
• Selcia
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec
In general, a company profile gives you the following information:
• Drug discovery revenue forecast from 2015 to 2025
• Historical and recent revenue figures
• Description of services and products
• Assessment of recent developments – mergers and acquisitions (M&A), collaborations, partnerships and alliances
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
How the Drug Discovery Outsourcing Market Forecast 2015-2025: Opportunities for Leading Companies report delivers
In summary, our 223-page report gives you the following knowledge:
• Revenue forecast to 2025 for the world drug discovery outsourcing market and 4 leading submarkets – Discover the industry’s prospects, finding promising areas for investment and revenues.
• Revenue forecasts to 2025 for the leading 13 national markets – US, Japan, Germany, France, UK, Italy, Spain, Brazil, Russia, China, India, South Korea, Mexico and the Rest of the World
• Assessment of 14 leading companies – hear about collaborations, partnerships, contracts and alliances and predicted revenues to 2025
• Analysis of what stimulates and restrains that industry and market – assess challenges and strengths, helping you compete and get advantages.
• View opinions from our survey, seeing interviews with leading drug discovery outsourcing experts.
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our study you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the drug discovery outsourcing market and leading CROs that offer these services. You find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 The Drug Discovery Outsourcing Market Overview
1.2 Drug Discovery Outsourcing Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharma Collaborations with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements
2.11 Glossary of Terms Related to Drug Discovery Outsourcing
3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2015-2025
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market Sectors
3.3 The Global Drug Discovery Outsourcing Market by Sector, 2014
3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2025
3.5 The Changing Market Shares by Sector, 2015-2025
3.6 The Global Chemistry Services Outsourcing Market, 2014
3.6.1 Libraries
3.6.2 Building Blocks
3.6.3 Compound Synthesis
3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2025
3.7 The Global Biology Services Outsourcing Market, 2014
3.7.1 Target Identification
3.7.2 Target Validation
3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2025
3.8 The Global Lead Optimisation Market, 2014
3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
3.8.2 The Global Lead Optimisation Market Forecast, 2015-2025
3.9 The Global Lead Identification and Screening Outsourcing Market, 2014
3.9.1 Methods of Screening in Drug Discovery
3.9.2 Primary Screening
3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-
2025
4. The Leading National Markets in the Drug Discovery Outsourcing Markets 2015-2025
4.1 Drug Discovery Outsourcing Overview
4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2014
4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2025
4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery
Outsourcing Market, 2015-2025
4.5 CAGRS of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2025
4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2014
4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2025
4.7.2 CAGRS by EU5 Region, 2015-2025
4.7.3 The EU5 Changing Market Shares by Country 2015-2025
4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.9.1 Challenges to China’s Growth
4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
5. Leading Companies in the Drug Discovery Outsourcing Market in 2015
5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
5.2 Characteristics of Leading Contract Research Organisations
5.2.1 A Highly Quality Workforce
5.2.2 Emphasis on Intellectual Property Protection
5.2.3 Long Term Working Relationship
5.2.4 Success in Project Completion
5.2.5 Internal Drug Discovery Programmes
5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
5.4 Albany Molecular Research (AMRI)
5.4.1 Sales and Recent Financial Performance, 2011-2013
5.4.2 AMRI’s Drug Discovery Services
5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
5.5 Aptuit
5.5.1 INDIGO: Accelerating Early Drug Candidates
5.5.2 Aptuit Clinical Trial Supplies
5.5.3 Strategic Partnerships, Acquisitions and Divestitures
5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
5.5.3.2 Aptuit’s Extended Partnership with GSK for Verona Centre
5.5.3.3 Partnership with Siena Biotech
5.5.3.4 Partnership with Laurus Labs
5.6 Charles River Laboratories
5.6.1 Sales and Recent Financial Performance, 2011-2013
5.6.2 Charles River Laboratories: An External Acquisition Strategy
5.6.2.1 Acquisition of ChanTest
5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
5.6.2.3 Acquisition of VivoPath
5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014
5.6.3.1 Charles River Laboratories: Financial Performance by Business Segment, 2013-2014
5.6.4 Charles River Laboratories Sales Forecast, 2015-2025
5.7 Covance (Acquired by LabCorp)
5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
5.7.2 Covance: Early Stage Discovery Efforts
5.7.3 Agreement with Sanofi
5.7.4 Agreement with Kellogg Company
5.7.5 Agreement with BioPontis Alliance
5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
5.7.7 Agreement with Eli Lilly
5.8 Cyprotex
5.8.1 Historical Revenue and Financial Performance, 2011-2013
5.8.2 Cyprotex: Revenue by Region, 2013
5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2025
5.9 Domainex
5.9.1 Drug Pipeline
5.9.2 TBK1/ IKKε Inhibitors
5.9.3 Methyltransferase (KMTS) Inhibitors
5.10 Evotec
5.10.1 Strategic Action Plan
5.10.2 Evotec: Revenue and Financial Analysis, 2010-2013
5.10.3 EVT Integrate and EVT Innovate
5.10.4 Partnerships with Pharma for Drug Discovery
5.10.4.1 Partnership with Sanofi
5.10.4.2 Extended Partnership with Evotec
5.10.4.3 Partnership with Johnson & Johnson
5.10.4.4 Partnership with AstraZeneca
5.10.4.5 Partnership with Bayer Pharma
5.10.4.6 Partnership with Boehringer Ingelheim Pharma
5.10.4.7 Collaboration with CHDI
5.10.4.8 Collaboration with Janssen
5.10.4.9 Collaboration with MedImmune
5.10.4.10 Collaboration with UCB Pharma
5.10.5 Evotec Sales Forecast, 2015-2025
5.11 GenScript
5.11.1 GenScript: Agreements and Partnerships
5.12 Pharmaceutical Product Development (PPD)
5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
5.12.1.1 Acquisition of Acurian
5.12.1.2 Partnership with Elan
5.12.1.3 Partnership with GSK
5.13 Quintiles
5.13.1Quintiles: Historical Revenue and Financial Performance, 2009-2013
5.13.2 Development Deal With Merck
5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs
5.13.4 Quintiles: Shedding Jobs
5.13.5 Quintiles Sales Forecast, 2015-2025
5.14 Selcia
5.14.1 A Strong Natural Product Chemistry Track Record
5.14.2 Initiative with the University of Edinburgh
5.14.3 Collaboration with Cantab
5.15 Viva Biotech
5.15.1 GPCR Targeted Discovery Programs
5.15.2 Antibody Therapeutics Discovery
5.16 WIL Research Laboratories
5.16.1 Focus on Preclinical Research
5.16.2 Acquisition of Ricerca Biosciences LLC
5.16.3 Acquisition of Midwest BioResearch
5.17 WuXi Apptec
5.17.1WuXi AppTec: Service Offerings
5.17.2 Acquisition of NextCODE Health
5.17.3 WuXi AppTec: Historical Revenue and Financial Performance, 2009-2013
5.17.4 WuXi AppTec: Laboratory Services Sales Forecast, 2015-2025
6. Qualitative Analysis of the Drug Discovery Outsourcing Market, 2015-2025
6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2015-2025
6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2015-2025
6.3 Strengths
6.3.1 Cost Reduction: A Central Driver for Outsourcing
6.3.2 Accelerating the Discovery of Drug Candidates
6.3.3 Growth of Virtual Pharma Companies
6.3.4 Reduction in R&D capacity Within Big Pharma
6.4 Weaknesses
6.4.1 Slowing Trajectory of Growth for R&D Spending
6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
6.5 Opportunities
6.5.1 The Available Scope for the Expansion of CROs
6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
6.5.3 Increasing Development of Biologics and Biosimilars
6.6 Threats
6.6.1 A Competitive Market is Increasing Consolidation
6.6.2 Threat of Private Public Alliances
6.6.3 Intellectual Property Leaks
6.6.4 Challenges of Technology Transfer
6.7 Porter’s Five Force Analysis of the Drug Discovery Outsourcing Market
6.7.1 Threat of New Entrants: Medium
6.7.2 Power of Suppliers: Medium
6.7.3 Threat of Substitutes: Medium
6.7.4 Power of Buyers: High
6.7.5 Rivalry Among Competitors: High
7. Expert Opinions
7.1 Interview with Dr Mario Polywka, Chief Operating Officer, Evotec
7.1.1 Bridging the Gap Between Academia and Big Pharma
7.1.2 Evotec: Specialises in Certain Disease Therapies
7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend
7.1.4 Strategies for Drug Discovery Outsourcing Expansion
7.1.5 Building Trust in Collaborations
7.1.6 Evotec: Proven Track Record of Success
7.2 Dr John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia
7.2.1 Growth in the Full Spectrum of Outsourcing Services
7.2.2 Natural Products: Increasing Source of Drug Discovery
7.2.3 Strong Pool of Early Drug Candidates
7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery
7.2.5 Selcia: Regional Base of Clients
7.2.6 Drug Discovery and Emerging Technologies
7.2.7 MedChemPlus Projects
7.2.8 Varied Customer Base
7.2.9 CROs: Improving Drug Discovery Productivity Levels?
7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit
7.3.1 End-to-End Drug Discovery Integration Growth
7.3.2 Whole Project Externalisation
7.3.3 Drug Discovery Outsourcing: One of Aptuit’s Fastest Growing Services
7.3.4 Aptuit INDiGO® Program
7.3.5 Aptuit Implementation Drug Discovery Acquisitions
7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery
7.3.7 Several Partners in the Drug Discovery Model
8. Conclusion
8.1 Market Overview
8.2 Lead Optimisation will be the Fastest Growing Sector
8.3 The Drug Discovery Outsourcing Market in Emerging Market Show Huge Gains
8.4 Continued Growth in Alliances and Collaborations
8.5 Concluding Remarks
List of Tables
Table 1.1 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 1.2 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 2.1 Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2015
Table 2.2 Selected Drug Discovery Outsourcing Alliances, 2013-2014
Table 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn),1980-2013
Table 3.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Sector, 2014
Table 3.3 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2014-2025
Table 3.4 The Global Drug Discovery Outsourcing Market: Revenue Share (%) by Sector, 2014, 2019 and 2025
Table 3.5 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2014-2025
Table 3.6 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2014-2025
Table 3.7 The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%) by Sector, 2014-2025
Table 3.8 Selected Source for Lead Compounds, 2015
Table 3.9 The Lead Identification and Screening Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn), Market Share (%) by Region, 2014
Table 4.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR
(%), CAGR (%) by Region, 2014-2025
Table 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2014, 2019, 2025
Table 4.4 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2014-2019, 2019-2025, 2014-2025
Table 4.5 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.6 The US Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.7 The EU5 Drug Discovery Outsourcing Market: Revenue ($m), Market Share (%) by Region, 2014
Table 4.8 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.9 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2014-2019, 2019-2025, and 2014-2025
Table 4.10 The EU5 Drug Discovery Outsourcing Market: Market Shares (%) by Country, 2014, 2019, 2025
Table 4.11 The German Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.12 The German Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.13 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.14 The UK Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank,
Market Share (%) and CAGR (%), 2014-2025
Table 4.15 The French Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.16 The French Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.17 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.18 The Italian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.19 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 4.20 The Spanish Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.21 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.24 The Chinese Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.26 The Indian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.27 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.28 The Brazilian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.29 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.30 The Russian Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.31 The South Korean Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.32 The South Korean Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.33 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 4.34 The Mexican Drug Discovery Outsourcing Market Forecast: Market Size ($bn), Rank, Market Share (%) and CAGR (%), 2014-2025
Table 4.35 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), AGR (%), 2011-2013
Table 5.2 AMRI: Service Offerings and Descriptions, 2015
Table 5.3 AMRI: Drug Discovery and Development Programmes and Project Stage
Table 5.4 AMRI (DDS) Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.5 Aptuit: Services Offered and their Descriptions, 2015
Table 5.6 Charles River Laboratories: Services Offered by Segment, 2015
Table 5.7 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2013
Table 5.8 Charles River Laboratories: Revenue ($m) by Segment, 2011-2013
Table 5.9 Charles River Laboratories: Revenue ($bn) by Business Segment, 2013-2014
Table 5.10 Charles River Laboratories Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.11 Covance: Historical Revenue ($bn) by Business Segment, 2010-2013
Table 5.12 Selected Cyprotex Partnerships, 2015
Table 5.13 Cyprotex: Historical Revenue ($m), (£m), AGR (%), 2011-2013
Table 5.14 Cyprotex: Revenue ($m), Revenue Share (%) by Region, 2013
Table 5.15 Cyprotex Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.16 Cyprotex Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.17 Evotec: Historical Revenue ($m), (€m), AGR(%), 2010-2013
Table 5.18 Evotec: Discovery Pipeline, 2015
Table 5.19 Evotec Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 5.20 GenScript: Services Offered and Descriptions, 2015
Table 5.21 Quintiles: Revenue ($bn), AGR (%), 2009-2013
Table 5.22 Quintiles Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
Table 5.23 Selcia: Drug Discovery Services Portfolio, 2015
Table 5.24 Viva Biotech: Service Offerings, 2015
Table 5.25 WuXi AppTec: Pharmaceutical Laboratory Services and Descriptions, 2015
Table 5.26 WuXi AppTec: Historical Revenue ($m), AGR (%) by Business Segment, 2009-2013
Table 5.27 WuXi AppTec Laboratory Services Forecast: Revenue ($m), AGR (%), CAGR (%), 2014-2025
Table 6.1 SWOT Analysis of the Drug Discovery Outsourcing Industry, 2015-2025
Table 8.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), CAGR (%), 2014, 2019, 2025
Table 8.2 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector,
2014, 2019, 2025
Table 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging Market, 2014, 2019 and 2025
List of Figures
Figure 1.1 The Drug Discovery Outsourcing Market: Overview of Submarkets
Figure 2.1 Selected Tasks being Outsourced in the Pharma Industry, 2015
Figure 2.2 Stages of the Drug Development Cycle
Figure 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 1980-2013
Figure 3.2 Attrition Rate of Compounds at the Developmental Stages
Figure 3.3 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Sector, 2014
Figure 3.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Sector, 2014
Figure 3.5 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 3.6 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Sector, 2019
Figure 3.7 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Sector, 2025
Figure 3.8 The Chemistry Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 3.9 The Biology Services Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 3.10 An Overview of ADMET Screening in Drug Discovery
Figure 3.11The Lead Optimisation Outsourcing Market Forecast: Revenue ($bn), AGR (%),
2014-2025
Figure 3.12 Typical Steps in the Lead Screening Process
Figure 3.13 The Lead Identification and Screening Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.1 The Global Drug Discovery Outsourcing Market: Revenue ($bn) by Region, 2014
Figure 4.2 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2014
Figure 4.3 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2019
Figure 4.4 The Global Drug Discovery Outsourcing Market: Market Share (%) by Region, 2025
Figure 4.5 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2014-2019
Figure 4.6 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2019-2025
Figure 4.7 The Global Drug Discovery Outsourcing Market Forecast: CAGR (%) by Region, 2014-2025
Figure 4.8 The US Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.9 The EU5 Drug Discovery Outsourcing Market: Market Revenue ($m) by Region, 2014
Figure 4.10 The EU5 Drug Discovery Outsourcing Market: Market Share (%) by Region, 2014
Figure 4.11 The EU5 Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 4.12 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2014-2019
Figure 4.13 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2019-2025
Figure 4.14 The EU5 Drug Discovery Outsourcing Market Forecast: CAGR (%) by Country, 2014-2025
Figure 4.15 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by
Country, 2019
Figure 4.16 The EU5 Drug Discovery Outsourcing Market Forecast: Market Shares (%) by
Country, 2025
Figure 4.17 The German Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 4.18 The UK Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%),
2014-2025
Figure 4.19 The French Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 4.20 The Italian Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 4.21 The Spanish Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 4.22 The Japanese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.23 The Chinese Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.24 The Chinese Population Demographics: Over 65 population and Forecast (millions), 1950, 2010, 2050
Figure 4.25 The Indian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.26 The Brazilian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.27 The Russian Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.28 The South Korean Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.29 The Mexican Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 4.30 The Rest of the World Drug Discovery Outsourcing Market Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 5.1 Albany Molecular Research (AMRI): Historical Revenue ($m), AGR (%), 2010-2013
Figure 5.2 AMRI (DDS) Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 5.3 Charles River Laboratories: Revenue ($m), AGR (%), 2011-2013
Figure 5.4 Charles River Laboratories: Revenue Share (%) by Segment, 2013
Figure 5.5 Charles River Laboratories: Revenue ($bn), 2013-2014
Figure 5.6 Charles River Laboratories: Revenue Share (%) by Business Segment, 2014
Figure 5.7 Charles River Laboratories Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 5.8 Covance: Historical Revenue ($bn), 2010-2013
Figure 5.9 Covance: Revenue Share (%) by Segment, 2013
Figure 5.10 Cyprotex: Historical Revenue (£m), AGR (%), 2011-2013
Figure 5.11 Cyprotex: Revenue Share (%) by Region, 2013
Figure 5.12 Cyprotex Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 5.13 Domainex: Drug Pipeline by Indication, 2015
Figure 5.14 Evotec: Historical Revenue (€m), AGR (%), 2010-2013
Figure 5.15 Evotec Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 5.16 Quintiles: Historical Revenue ($bn), AGR (%), 2009-2013
Figure 5.17 Quintiles Forecast: Revenue ($bn), AGR (%), 2014-2025
Figure 5.18 WuXi AppTec: Historical Revenue ($m) by Business Segment, 2009-2013
Figure 5.19 WuXi AppTec Laboratory Services Forecast: Revenue ($m), AGR (%), 2014-2025
Figure 6.1 The Drug Discovery Outsourcing Market: Drivers and Restraints, 2015-2025
Figure 6.2 Porter’s Five Analysis of the Companion Diagnostics Market, 2015-2025
Figure 8.1 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn), 2014, 2019, 2025
Figure 8.2 The Global Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Sector, 2014, 2019, 2025
Figure 8.3 The Drug Discovery Outsourcing Market Forecast: Revenue ($bn) by Emerging
Market, 2014, 2019 and 2025
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
